MannKind Corporation (MNKD)
NASDAQ: MNKD · Real-Time Price · USD
3.730
-0.120 (-3.12%)
At close: Aug 13, 2026, 4:00 PM EDT
3.750
+0.020 (0.54%)
After-hours: Aug 13, 2026, 7:56 PM EDT
MannKind Employees
As of December 31, 2025, MannKind had 592 total employees, including 591 full-time and 1 part-time employees. The number of employees increased by 185 or 45.45% compared to the previous year.
Employees
592
Change (1Y)
185
Growth (1Y)
45.45%
Revenue / Employee
$664,914
Profits / Employee
-$73,672
Market Cap
1.20B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 592 | 185 | 45.45% | 591 | 1 |
| Dec 31, 2024 | 407 | -7 | -1.69% | 403 | 4 |
| Dec 31, 2023 | 414 | 19 | 4.81% | 411 | 3 |
| Dec 31, 2022 | 395 | 46 | 13.18% | 391 | 4 |
| Dec 31, 2021 | 349 | 108 | 44.81% | 348 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| Immatics | 678 |
| MeiraGTx Holdings | 409 |
| EyePoint | 214 |
| Alpha Tau Medical | 121 |
| Cullinan Therapeutics | 109 |
| Vor Biopharma | 76 |
| Seaport Therapeutics | 58 |
MNKD News
- 7 days ago - MannKind price target lowered to $13 from $14 at Wells Fargo - TheFly
- 8 days ago - MannKind reports Q2 EPS (6c), consensus 2c - TheFly
- 8 days ago - MannKind Earnings Call Transcript: Q2 2026 - Transcripts
- 8 days ago - MannKind Earnings release: Q2 2026 - Filings
- 8 days ago - MannKind Quarterly report: Q2 2026 - Filings
- 8 days ago - MannKind Slides: Q2 2026 - Filings
- 8 days ago - MannKind Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 14 days ago - MannKind price target raised to $14 from $11 at Wells Fargo - TheFly